Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00613795 · ClinicalTrials.gov registry record · Phase 3
Lactobacillus GG in the Prophylaxis of Ventilator Associated Pneumonia
A Phase 3 study, sponsored by Creighton University.
- Completed
- Registry status
- Phase 3
- Development phase
- 125
- Enrollment target
NCT00613795 is a Phase 3 study that has completed, run by Creighton University. The registered enrollment target is 125 participants.
The verdict
NCT00613795, a Phase 3 study, has completed, sponsored by Creighton University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 125 participants
- Enrollment target
Study Summary
This study utilizes lactobacillus, or probiotics, delivered twice daily to the mouth and stomach, via feeding tube, in effort to determine whether the oral administration of a naturally occurring Lactobacillus species reduces the incidence of ventilator associated pneumonia therefore reducing intensive care unit(ICU)complications.
Interventions
- DIETARY_SUPPLEMENT placebo
- DIETARY_SUPPLEMENT Lactobacillus GG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2004-08 |
| Est. Completion | 2009-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00613795
The ClinicalTrials.gov registry entry for NCT00613795 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Creighton University, which has 98 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00613795 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00613795 about?
NCT00613795 is a clinical study titled "Lactobacillus GG in the Prophylaxis of Ventilator Associated Pneumonia". This study utilizes lactobacillus, or probiotics, delivered twice daily to the mouth and stomach, via feeding tube, in effort to determine whether the oral administration of a naturally occurring Lactobacillus species reduces the incidence of ventilator associated pneumonia therefore reducing intens...
What is the current status of trial NCT00613795?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 125 participants. The study started on 2004-08. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00613795?
The interventions under investigation include: placebo (DIETARY_SUPPLEMENT), Lactobacillus GG (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00613795?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.